Daniel N. Swisher, Jr
2008 - Sunesis Pharmaceuticals
In 2008, Daniel N. Swisher, Jr earned a total compensation of $404.1K as Chief Executive Officer and President at Sunesis Pharmaceuticals.
Compensation breakdown
| Salary | $403,125 |
|---|---|
| Other | $930 |
| Total | $404,055 |
Swisher received $403.1K in salary, accounting for 100% of the total pay in 2008.
Swisher also received $930 in other compensation.
Rankings
In 2008, Daniel N. Swisher, Jr's compensation ranked 7,129th out of 9,135 executives tracked by ExecPay. In other words, Swisher earned more than 22.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,129 out of 9,135 | 22nd |
Division Manufacturing | 2,669 out of 3,436 | 22nd |
Major group Chemicals And Allied Products | 606 out of 815 | 26th |
Industry group Drugs | 429 out of 597 | 28th |
Industry Pharmaceutical Preparations | 306 out of 408 | 25th |
Source: SEC filing on April 28, 2010.
Swisher's colleagues
We found three more compensation records of executives who worked with Daniel N. Swisher, Jr at Sunesis Pharmaceuticals in 2008.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019